ESR Essentials: imaging in fibrotic lung diseases-practice recommendations by the European Society of Thoracic Imaging.
Diagnostic imaging
Disease progression
Lung diseases (interstitial)
Pulmonary fibrosis
Tomography (x-ray computed)
Journal
European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774
Informations de publication
Date de publication:
07 Sep 2024
07 Sep 2024
Historique:
received:
25
05
2024
accepted:
03
08
2024
revised:
29
07
2024
medline:
7
9
2024
pubmed:
7
9
2024
entrez:
6
9
2024
Statut:
aheadofprint
Résumé
Fibrotic lung diseases (FLDs) represent a subgroup of interstitial lung diseases (ILDs), which can progress over time and carry a poor prognosis. Imaging has increased diagnostic discrimination in the evaluation of FLDs. International guidelines have stated the role of radiologists in the diagnosis and management of FLDs, in the context of the interdisciplinary discussion. Chest computed tomography (CT) with high-resolution technique is recommended to correctly recognise signs, patterns, and distribution of individual FLDs. Radiologists may be the first to recognise the presence of previously unknown interstitial lung abnormalities (ILAs) in various settings. A systematic approach to CT images may lead to a non-invasive diagnosis of FLDs. Careful comparison of serial CT exams is crucial in determining either disease progression or supervening complications. This 'Essentials' aims to provide radiologists a concise and practical approach to FLDs, focusing on CT technical requirements, pattern recognition, and assessment of disease progression and complications. Hot topics such as ILAs and progressive pulmonary fibrosis (PPF) are also discussed. KEY POINTS: Chest CT with high-resolution technique is the recommended imaging modality to diagnose pulmonary fibrosis. CT pattern recognition is central for an accurate diagnosis of fibrotic lung diseases (FLDs) by interdisciplinary discussion. Radiologists are to evaluate disease behaviour by accurately comparing serial CT scans.
Identifiants
pubmed: 39242399
doi: 10.1007/s00330-024-11054-2
pii: 10.1007/s00330-024-11054-2
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Wijsenbeek M, Suzuki A, Maher TM (2022) Interstitial lung diseases. Lancet 400:769–786
doi: 10.1016/S0140-6736(22)01052-2
pubmed: 35964592
Flaherty KR, Wells AU, Cottin V et al (2019) Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med 381:1718–1727
doi: 10.1056/NEJMoa1908681
pubmed: 31566307
Raghu G, Remy-Jardin M, Richeldi L et al (2022) Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 205:e18–e47
doi: 10.1164/rccm.202202-0399ST
pubmed: 35486072
pmcid: 9851481
Hatabu H, Hunninghake GM, Richeldi L et al (2020) Interstitial lung abnormalities detected incidentally on CT: a position paper from the Fleischner Society. Lancet Respir Med 8:726–737
doi: 10.1016/S2213-2600(20)30168-5
pubmed: 32649920
pmcid: 7970441
Humphries SM, Swigris JJ, Brown KK et al (2018) Quantitative high-resolution computed tomography fibrosis score: performance characteristics in idiopathic pulmonary fibrosis. Eur Respir J 52:1801384
doi: 10.1183/13993003.01384-2018
pubmed: 30139770
Raghu G, Remy-Jardin M, Myers JL et al (2018) Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 198:e44–e68
doi: 10.1164/rccm.201807-1255ST
pubmed: 30168753
Richeldi L, Collard HR, Jones MG (2017) Idiopathic pulmonary fibrosis. Lancet 389:1941–1952
doi: 10.1016/S0140-6736(17)30866-8
pubmed: 28365056
Hunninghake GM, Quesada-Arias LD, Carmichael NE et al (2020) Interstitial lung disease in relatives of patients with pulmonary fibrosis. Am J Respir Crit Care Med 201:1240–1248
doi: 10.1164/rccm.201908-1571OC
pubmed: 32011908
pmcid: 7233344
Walsh SLF, Devaraj A, Enghelmayer JI et al (2018) Role of imaging in progressive-fibrosing interstitial lung diseases. Eur Respir Rev 27:180073
doi: 10.1183/16000617.0073-2018
pubmed: 30578332
pmcid: 9488692
Gaeta M, Minutoli F, Girbino G et al (2013) Expiratory CT scan in patients with normal inspiratory CT scan: a finding of obliterative bronchiolitis and other causes of bronchiolar obstruction. Multidiscip Respir Med 8:44
doi: 10.1186/2049-6958-8-44
pubmed: 23835554
pmcid: 3710098
Prosch H, Schaefer-Prokop CM, Eisenhuber E et al (2013) CT protocols in interstitial lung diseases—a survey among members of the European Society of Thoracic Imaging and a review of the literature. Eur Radiol 23:1553–1563
doi: 10.1007/s00330-012-2733-6
pubmed: 23239063
Raghu G, Remy-Jardin M, Ryerson CJ et al (2020) Diagnosis of hypersensitivity pneumonitis in adults. An official ATS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 202:e36–e69
doi: 10.1164/rccm.202005-2032ST
pubmed: 32706311
pmcid: 7397797
Gaillandre Y, Duhamel A, Flohr T et al (2023) Ultra-high resolution CT imaging of interstitial lung disease: impact of photon-counting CT in 112 patients. Eur Radiol 33:5528–5539
doi: 10.1007/s00330-023-09616-x
pubmed: 37071165
Hariri LP, Roden AC, Chung JH et al (2021) The role of surgical lung biopsy in the diagnosis of fibrotic interstitial lung disease: perspective from the Pulmonary Fibrosis Foundation. Ann Am Thorac Soc 18:1601–1609
doi: 10.1513/AnnalsATS.202009-1179FR
pubmed: 34004127
Bankier AA, MacMahon H, Colby T et al (2024) Fleischner Society: glossary of terms for thoracic imaging. Radiology 310:e232558
doi: 10.1148/radiol.232558
pubmed: 38411514
Watadani T, Sakai F, Johkoh T et al (2013) Interobserver variability in the CT assessment of honeycombing in the lungs. Radiology 266:936–944
doi: 10.1148/radiol.12112516
pubmed: 23220902
Lee KS, Im Y (2022) Traction bronchiectasis and bronchiolectasis at CT predicts survival in individuals with interstitial lung abnormalities: the COPDGene study. Radiology 304:702–703
doi: 10.1148/radiol.220833
pubmed: 35638933
Nasser M, Larrieu S, Si-Mohamed S et al (2021) Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study). Eur Respir J 57:2002718
doi: 10.1183/13993003.02718-2020
pubmed: 32943410
pmcid: 8411897
Jacob J, Aksman L, Mogulkoc N et al (2020) Serial CT analysis in idiopathic pulmonary fibrosis: comparison of visual features that determine patient outcome. Thorax 75:648–654
doi: 10.1136/thoraxjnl-2019-213865
pubmed: 32345689
Walsh SLF, Mackintosh JA, Calandriello L et al (2022) Deep learning-based outcome prediction in progressive fibrotic lung disease using high-resolution computed tomography. Am J Respir Crit Care Med 206:883–891
doi: 10.1164/rccm.202112-2684OC
pubmed: 35696341
Ledda RE, Milanese G, Milone F et al (2022) Interstitial lung abnormalities: new insights between theory and clinical practice. Insights Imaging 13:6
doi: 10.1186/s13244-021-01141-z
pubmed: 35032230
pmcid: 8761184
Kolb M, Bondue B, Pesci A et al (2018) Acute exacerbations of progressive-fibrosing interstitial lung diseases. Eur Respir Rev 27:180071
doi: 10.1183/16000617.0071-2018
pubmed: 30578331
pmcid: 9488799
Collard HR, Ryerson CJ, Corte TJ et al (2016) Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report. Am J Respir Crit Care Med 194:265–275
doi: 10.1164/rccm.201604-0801CI
pubmed: 27299520
Remy-Jardin M, Ryerson CJ, Schiebler ML et al (2021) Imaging of pulmonary hypertension in adults: a position paper from the Fleischner Society. Eur Respir J 57:2004455
doi: 10.1183/13993003.04455-2020
pubmed: 33402372
Valentini A, Franchi P, Cicchetti G et al (2023) Pulmonary hypertension in chronic lung diseases: what role do radiologists play? Diagnostics 13:1607
doi: 10.3390/diagnostics13091607
pubmed: 37174998
pmcid: 10178805
Fisher DA, Murphy MC, Montesi SB et al (2022) Diagnosis and treatment of lung cancer in the setting of interstitial lung disease. Radiol Clin North Am 60:993–1002
doi: 10.1016/j.rcl.2022.06.010
pubmed: 36202484
pmcid: 9969995
Flaherty KR, King Jr TE, Raghu G et al (2004) Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med 170:904–910
doi: 10.1164/rccm.200402-147OC
pubmed: 15256390
Flaherty KR, Andrei AC, King Jr TE et al (2007) Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am J Respir Crit Care Med 175:1054–1060
doi: 10.1164/rccm.200606-833OC
pubmed: 17255566
pmcid: 1899268
Walsh SL, Wells AU, Desai SR et al (2016) Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study. Lancet Respir Med 4:557–565
doi: 10.1016/S2213-2600(16)30033-9
pubmed: 27180021
Biglia C, Ghaye B, Reychler G et al (2019) Multidisciplinary management of interstitial lung diseases: a real-life study. Sarcoidosis Vasc Diffus Lung Dis 36:108–115
De Sadeleer LJ, Meert C, Yserbyt J et al (2018) Diagnostic ability of a dynamic multidisciplinary discussion in interstitial lung diseases: a retrospective observational study of 938 cases. Chest 153:1416–1423
doi: 10.1016/j.chest.2018.03.026
pubmed: 29608882